Abstract
Purpose
Inadequate retinal oxygenation occurs in many vision-threatening retinal diseases, including diabetic retinopathy, retinal vascular occlusions, and age-related macular degeneration. Therefore, techniques that assess retinal oxygenation are necessary to understand retinal physiology in health and disease. The purpose of the current study is to report a method for the three-dimensional (3D) imaging of retinal tissue oxygen tension (tPO2) in rats.
Methods
Imaging was performed in Long Evans pigmented rats under systemic normoxia (N = 6) or hypoxia (N = 3). A vertical laser line was horizontally scanned on the retina and a series of optical section phase-delayed phosphorescence images were acquired. From these images, phosphorescence volumes at each phase delay were constructed and a 3D retinal tPO2 volume was generated. Retinal tPO2 volumes were quantitatively analyzed by generating retinal depth profiles of mean tPO2 (MtPO2) and the spatial variation of tPO2 (SVtPO2). The effects of systemic condition (normoxia/hypoxia) and retinal depth on MtPO2 and SVtPO2 were determined by mixed linear model.
Results
Each 3D retinal tPO2 volume was approximately 500 × 750 × 200 μm (horizontal × vertical × depth) and consisted of 45 en face tPO2 images through the retinal depth. MtPO2 at the chorioretinal interface was significantly correlated with systemic arterial oxygen tension (P = 0.007; N = 9). There were significant effects of both systemic condition and retinal depth on MtPO2 and SVtPO2, such that both were lower under hypoxia than normoxia and higher in the outer retina than inner retina (P < 0.001).
Conclusion
For the first time, 3D imaging of retinal tPO2 was demonstrated, with potential future application for assessment of physiological alterations in animal models of retinal diseases.
Keywords: Rat, retina, tissue oxygen tension, three-dimensional imaging, phosphorescence lifetime imaging
Introduction
The retina is one of the most metabolically active tissues in the human body.1 To maintain visual function, oxygen is continuously delivered to the tissue by the retinal and choroidal circulations.2,3 The contributions of these circulations create steady-state gradients of oxygen through the retinal depth.4,5 Inadequate retinal oxygenation has been implicated in many retinal diseases, including diabetic retinopathy,6,7 central retinal vein occlusions,8,9 and age-related macular degeneration.10 Therefore, techniques that assess retinal tissue oxygen content are necessary to better understand retinal pathophysiology.
Several imaging methods have been developed to measure the oxygen content of the retinal vasculature, including spectrophotometry,11–14 phosphorescence lifetime imaging,15,16 photoacoustic ophthalmoscopy,17 and visible optical coherence tomography.18 However, these techniques can only provide an indirect assessment retinal tissue oxygenation from measurements of vascular oxygen content.12 In contrast, oxygen-sensitive microelectrodes directly measure retinal tissue oxygen tension (tPO2) through the retinal depth.4,19–21 While the oxygen microelectrode technique is considered to be the gold standard due to high sensitivity and depth discrimination, it is invasive and provides limited spatial assessment of tPO2. These limitations were addressed in part by two-dimensional phosphorescence lifetime imaging,15,16 which provided non-invasive, depth-resolved measurements of tPO2 at vertically contiguous retinal locations.22 However, since this method did not measure retinal tPO2 in three dimensions (3D), identification and assessment of physiological and pathological variations in tPO2 across regions of the retina were limited. In the current study, we addressed this limitation by volumetric retinal tPO2 imaging using our previously developed system for the 3D imaging of oxygen tension within the retinal vasculature.23 This imaging technique overcomes the spatial limitations of existing methods and can provide valuable information about variations in tPO2 under physiological and pathological conditions.
Materials and methods
Animals
Nine Long Evans pigmented rats (weight: 300–600 g) were used in this study. The animals were treated in compliance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Anesthesia was induced with intraperitoneal injections of ketamine (100 mg/kg) and xylazine (5 mg/kg), and was maintained during imaging by supplemental doses of ketamine (20 mg/kg) and xylazine (1 mg/kg). An oxygen-sensitive molecular probe, Oxyphor R2 (Oxygen Enterprises, Ltd., Philadelphia, PA) was dissolved in saline and 3 μL (0.5 mM) was injected intravitreally 1 day prior to imaging, as previously described.22
Two separate groups of rats were ventilated mechanically (Harvard Apparatus Inc., South Natick, MA) with either 21%/30% fraction of inspired oxygen (FiO2) to maintain systemic normoxia (N = 6) or 10% FiO2 to induce systemic hypoxia (N = 3), as previously reported.24,25 One rat from the normoxia cohort was also ventilated under hypoxia for comparative visualization of tPO2 within the same retinal region. To verify the systemic condition of rats, arterial oxygen tension (PaO2), carbon dioxide tension (PaCO2), and blood pH were measured by a blood gas analyzer (Radiometer, Westlake, OH, or Idexx Vetstat, Westbrook, ME) using blood drawn from a catheter inserted into the femoral artery. Body temperature was maintained at 37°C using an animal holder with a closed-loop copper tubing water heater. Prior to imaging, pupils were dilated with 2.5% phenylephrine and 1% tropicamide. One percent hydroxypropyl methylcellulose and a glass cover slip were applied to the cornea to eliminate the cornea’s refractive power and to prevent corneal dehydration during imaging.
3D retinal tissue oxygen tension imaging
Our previously described optical section phosphorescence imaging system23 was used for the 3D imaging of retinal tPO2. Briefly, a slitlamp biomicroscope was modified to accommodate a laser (535 nm), an optical chopper, a rotational galvonometer with an attached mirror, a high-pass filter with 650 nm cutoff, and an intensified charge-coupled device (ICCD) camera. The laser was projected at an oblique angle to the retina as a ~ 1 mm vertical line and was modulated by the optical chopper at 1.6 kHz. The laser line was horizontally scanned across the retina, and phosphorescence emission was selectively imaged at each location using the high-pass filter placed in front of the ICCD camera. At each retinal scan location, a series of 6 or 10 phase-delayed, optical section phosphorescence images were acquired by setting incremental delays between the modulated laser and intensifier gain of the ICCD camera. Since the excitation laser and the imaging paths were not coaxial, phosphorescence across the retinal depth appeared laterally displaced in the optical section phosphorescence images.22 Imaging was performed in one eye of each animal, either temporal or nasal to the optic disc. During imaging, room lights were off and rats were light-adapted due to the scanning laser illumination.
A schematic diagram of the methodology for generating 3D retinal tPO2 volumes is shown in Figure 1. The vertical laser line was horizontally scanned across the retina in 9 μm steps (Figure 1A) and optical section phosphorescence images in the y–z plane of the retina were acquired at locations along the x-axis. The number of scan steps ranged from 14–45, depending on the eye curvature and dilated pupil size. Optical section phosphorescence images acquired at each phase delay were stacked along the x-axis to form phase-delayed phosphorescence volumes (Figure 1B). The volumes were flattened to remove the effect of the eye curvature and then smoothed by a 3D anisotropic averaging filter (2 × 6 × 4 pixels in the x, y and z-axes, respectively) (Figure 1C). This filter size was selected to smooth each voxel of the phosphorescence volume equally in all dimensions (18 μm × 18 μm × 18 μm). Using a frequency domain technique,15,16 phosphorescence lifetime was determined at each voxel from the phase-delayed phosphorescence volumes and oxygen tension was then calculated using the Stern–Volmer equation to generate a 3D retinal tPO2 volume (Figure 1D). All image reconstruction and processing was performed using customized algorithms developed in Matlab (MathWorks, Natick, MA).
Figure 1.
A schematic diagram illustrating the steps for the generation of a retinal tissue oxygen tension (tPO2) volume. (A) A vertical laser line is scanned laterally across the rat retina, as indicated by green lines, to acquire a series of phase-delayed optical section phosphorescence images. (B) The series of zero-phase delay optical section phosphorescence images are stacked along the x-axis. Vertical red lines on the rightmost optical section phosphorescence image indicate vitreoretinal (left) and chorioretinal (right) interfaces. (C) The zero-phase delay phosphorescence volume is shown. (D) Using the set of phase-delayed phosphorescence volumes, the phosphorescence lifetime was calculated at each voxel to generate a retinal tPO2 volume, shown in pseudo color. Color bar indicates tPO2 between 0 and 50 mmHg. (E) The tPO2 volume contains 45 en face tPO2 images in x–y planes across the retinal depth. Arrows (from left to right) point to en face tPO2 images at 0%, 33%, 66% and 100% retinal depth.
The chorioretinal and vitreoretinal interfaces were designated from the tPO2 volume as the location of maximal tPO2 and 200 μm anterior to the chorioretinal interface,26 respectively. The retinal tPO2 volume consisted of 45 en face tPO2 images in the x–y plane, extending from the vitreoretinal interface (en face tPO2 image 1 at 0% retinal depth) to the chorioretinal interface (en face tPO2 image 45 at 100% retinal depth) (Figure 1E). The inner and outer retinal volumes were defined as the inner and outer 50% of the total retinal volume19,21,26 and extended from en face tPO2 images 1 to 22 and 23 to 45, respectively.
Data analysis
From compiled data in all rats, the relationship between mean tPO2 of en face image 45 and systemic PaO2 was assessed by linear regression analysis. From each rat and each en face tPO2 depth, the mean tPO2 (MtPO2, rat, depth) and spatial variation of tPO2 (SVtPO2, rat, depth) was calculated. Spatial variation represents the lateral variability of tPO2 in each en face image and was calculated as the standard deviation of tPO2. Combining measurements of MtPO2, rat, depth and SVtPO2, rat, depth from all en face images in all rats, MtPO2 and SVtPO2 depth profiles under both systemic conditions were generated. Inter-animal variability was assessed by standard deviation of MtPO2 and SVtPO2 measurements at every retinal depth. The effects of systemic condition (normoxia, hypoxia) and retinal depth on MtPO2 and SVtPO2 were determined by mixed linear model. In one retinal region that encompassed both an inferior artery and a superior vein, a mean inner retinal en face tPO2 image (average of en face images 1–22) was generated. The relationship between tPO2 and vertical distance along the image (averaged over 30 μm vertical contiguous regions) was determined by linear regression analysis. All statistical analyses were performed using SPSS statistical software (version 22, SPSS, Chicago, IL, USA). Statistical significance was accepted at P ≤ 0.05.
Results
Qualitative evaluation of tPO2 volumes
All tPO2 volumes were inspected for qualitatively recognizable characteristics. Representative tPO2 volumes generated at the same retinal region (indicated in green; Figure 2A) in a rat under normoxia (Figure 2B) and hypoxia (Figure 2C) are shown. From these volumes, en face tPO2 images at four retinal depths under normoxia and hypoxia are displayed (Figure 2D). As expected, all volumes exhibited greater tPO2 at the chorioretinal interface compared to the inner retina, and volumes under hypoxia demonstrated lower tPO2 compared to those under normoxia. Further, tPO2 changed smoothly across each volume, without abrupt variations in tPO2. Retinal vessels were not visible on most tPO2 volumes.
Figure 2.
(A) Representative retinal region imaged in a rat, indicated by green lines superimposed on the red-free image. Retinal tissue oxygen tension (tPO2) volumes generated in the same retinal region under normoxia (B) and hypoxia (C). (D) From the tPO2 volumes, en face tPO2 images at four retinal depths under normoxia and hypoxia are displayed. Color bar indicates tPO2 in mmHg.
Quantitative analysis of tPO2 volumes
The PaO2, PaCO2 and pH levels of rats under systemic normoxia were 95 ± 15 mmHg, 43 ± 13 mmHg, and 7.4 ± 0.15, respectively. For rats under systemic hypoxia, the PaO2, PaCO2, and pH were 32 ± 3.5 mmHg, 34 ± 5.6 mmHg, and 7.4 ± 0.07, respectively. As shown in Figure 3, MtPO2 at the chorioretinal interface was linearly correlated with systemic PaO2 (R = 0.82, P = 0.007, N = 9).
Figure 3.
Mean retinal tissue oxygen tension (MtPO2) at the chorioretinal interface plotted as a function of systemic arterial oxygen tension (PaO2). Compiled data from nine rats.
Retinal MtPO2 depth profiles compiled from data obtained in all rats stratified by systemic condition are shown in Figure 4A. At each retinal depth, MtPO2 was lower under hypoxia than under normoxia. Under both systemic conditions, MtPO2 increased with retinal depth, indicating lower tPO2 in the inner retina and higher tPO2 toward the chorioretinal interface. Retinal SVtPO2 depth profiles compiled from data obtained in all rats stratified by systemic condition are shown in Figure 4B. Under normoxia, SVtPO2 was approximately 5 and 8 mmHg in inner retinal and outer retinal layers, respectively. Moreover, inter-animal variability in SVtPO2 was around 1 mmHg in the inner retina and 2.5 mmHg in the outer retina. SVtPO2 was lower at each retinal depth under hypoxia as compared to normoxia and highest at the chorioretinal interface under both systemic conditions. There were significant effects of systemic oxygen condition (normoxia, hypoxia) and retinal depth on both MtPO2 and SVtPO2 (P < 0.001). In a retinal region that encompassed a horizontally oriented retinal vein superiorly and an artery inferiorly (Figure 2), the fit from the linear regression between inner retinal tPO2 and the vertical axis was significant under normoxia (R = 0.88, P < 0.001, N = 30).
Figure 4.
(A) Mean retinal tissue oxygen tension (MtPO2) depth profile under normoxia (red, N = 6) and hypoxia (blue, N = 3). (B) Retinal tissue oxygen tension spatial variation (SVtPO2) depth profile under normoxia (red) and hypoxia (blue). Error bars indicate standard error of the means.
Discussion
In the current study, we report a technique for imaging of retinal tissue oxygen tension in three dimensions. Volumetric imaging of retinal tPO2 is essential to identify and assess the lateral variations of retinal oxygenation that occur under normal physiological and pathological conditions. Retinal tPO2 volumes displayed a lower tPO2 under hypoxia than normoxia, and all volumes displayed greater tPO2 toward the choroid, as expected. However, despite retention of the oxyphor only in the extravascular space, retinal vessels, which were devoid of phosphorescence signal, could not be visually identified on most tPO2 volumes. This was mainly due to the scatter of phosphorescence within the retinal tissue.
In the current study, the MtPO2 depth profiles compiled from all rats under normoxia demonstrated a large oxygen gradient in the outer retina with the greatest MtPO2 occurring at the chorioretinal interface, consistent with previous studies.4,19,22 This oxygen gradient is necessary to drive oxygen from the choroid to the photoreceptor inner segments.4,27 There was also a significant difference in MtPO2 at each retinal depth between normoxia and hypoxia, consistent with the findings of previous studies.5,22,28 However, absolute measurements of tPO2 through the retinal depth were generally lower than those reported in previous studies. In the current study, inner retinal MtPO2 and maximal MtPO2 under normoxia (18 mmHg, 30 mmHg) were lower than those in light-adapted rats measured by the oxygen microelectrode technique (29 mmHg, 45 mmHg)19 and phosphorescence lifetime imaging (30 mmHg, 50 mmHg),22 while they were more comparable to other published values measured using the oxygen microelectrode technique (15 mmHg, 50 mmHg),4 (13 mmHg, 35 mmHg).29
In the current study, we report SVtPO2 for the first time, revealing physiological variations of tPO2 across retinal regions. Under normoxia, lateral retinal tPO2 variability of 5–8 mmHg was demonstrated and is likely due to the net result of oxygen diffusional gradients within the tissue under steady state. Previously, variations in retinal tPO2 were suggested based only on differences in pre-retinal oxygen tension between arteries and veins.30–32 From compiled data in all rats, SVtPO2 increased with retinal depth and was greatest toward the choroid (8 mmHg), consistent with previous studies that reported similar variations in rat19,22,26 and cat5,21 under light-adapted conditions. Spatial variation of tPO2 was also depicted by demonstrating a gradient in inner retinal tPO2 between an artery and vein pair. This can be attributed to the reduction of oxygen tension in the capillary bed as blood passes from artery to vein, as well as oxygen diffusion to the retinal tissue between vessels.33 Additionally, from compiled data in all rats, SVtPO2 was lower under hypoxia than normoxia, indicating tPO2 is less variable during systemic hypoxia. Since the inner retinal tPO2 range should be related to the difference between the retinal arterial and venous oxygen tension, a decrease in the arteriovenous oxygen tension difference during hypoxia should reduce the SVtPO2. Indeed, a decrease in the retinal arteriovenous oxygen tension difference was previously reported under hypoxia.24 However, a floor effect on tPO2 during hypoxia may be present, which can also account for the decreased SVtPO2. Nevertheless, SVtPO2 can be a valuable metric and may be used to characterize tPO2 lateral variations across retinal en face images for detection of abnormalities, such as retinopathies characterized by multifocal pathologies.
There were several limitations of the current study. First, due to the use of laser excitation for phosphorescence lifetime imaging, data can only be obtained in light-adapted rats. Second, intraretinal phosphorescence scattering may reduce depth resolution and alter the tPO2 depth profiles, though the general trend of tPO2 retinal depth profiles was similar to that obtained by previous techniques. Third, due to the inverse non-linear relationship between phosphorescence lifetime and tPO2, this method is less sensitive to the detection of high tPO2, resulting in greater measurement variability. This limitation may, at least in part, account for the observation of higher tPO2 variability near the choroid. Fourth, eye motion that occurs due to animal respiration during imaging can create shifts between consecutive image locations or blurring of images. To minimize the contributions of these factors, the phosphorescence volumes were smoothed in post-processing, which decreased variations and may have altered calculation of phosphorescence life-time. However, since comparison of tPO2 was based on data from multiple animals, this image processing step likely minimally affected the results. Last, the calculation of tPO2 from phosphorescence lifetime relied on oxyphor constants that were derived from ex vivo experiments, which may be different from those in the living retinal tissue. This may affect absolute tPO2 values, the possibility of which cannot be excluded in this study.
In conclusion, we demonstrated a technique for imaging of retinal tissue oxygen tension in three dimensions in rats. This optical imaging technique is a promising tool for detecting lateral spatial variations in retinal tissue oxygen tension in animal models of retinal diseases.
Acknowledgments
The authors would like to acknowledge the contributions of Tara Nguyen and Marek Mori for animal care and data acquisition.
Funding
This study was supported by NIH grants EY017918 and EY001792, Senior Scientific Investigator award (MS) and an unrestricted departmental grant from Research to Prevent Blindness.
Footnotes
Color versions of one or more of the figures in the article can be found online at www.tandfonline.com/ICEY.
Declaration of interests
None (AEF, JW, PT, NPB); patent (MS).
Mahnaz Shahidi holds a patent for the imaging technology. None of the authors have received financial support or have personal financial interest relevant to the topic of the manuscript.
References
- 1.Trick GL, Berkowitz BA. Retinal oxygenation response and retinopathy. Prog Retin Eye Res. 2005;24(2):259–74. doi: 10.1016/j.preteyeres.2004.08.001. [DOI] [PubMed] [Google Scholar]
- 2.Kiel JW. The ocular circulation. Morgan & Claypool Life Sciences; San Rafael, CA, USA: 2010. http://www.ncbi.nlm.nih.gov/books/NBK53329/ [PubMed] [Google Scholar]
- 3.Dartt DA, Besharse JC, Dana R. Encyclopedia of the eye. Elsevier, Academic Press; Cambridge, MA, USA: 2010. [Google Scholar]
- 4.Cringle SJ, Yu DY, Yu PK, Su EN. Intraretinal oxygen consumption in the rat in vivo. Invest Ophthalmol Vis Sci. 2002;43(6):1922–27. [PubMed] [Google Scholar]
- 5.Linsenmeier RA, Braun RD. Oxygen distribution and consumption in the cat retina during normoxia and hypoxemia. J Gen Physiol. 1992;99(2):177–97. doi: 10.1085/jgp.99.2.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Gariano RF, Gardner TW. Retinal angiogenesis in development and disease. Nature. 2005;438(7070):960–66. doi: 10.1038/nature04482. [DOI] [PubMed] [Google Scholar]
- 7.Chan-Ling T, Gock B, Stone J. The effect of oxygen on vasoformative cell division. Evidence that ‘physiological hypoxia’ is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci. 1995;36(7):1201–14. [PubMed] [Google Scholar]
- 8.Traustason S, La Cour M, Larsen M. Retinal vascular oximetry during ranibizumab treatment of central retinal vein occlusion. Br J Ophthalmol. 2014;98(9):1208–11. doi: 10.1136/bjophthalmol-2013-304580. [DOI] [PubMed] [Google Scholar]
- 9.Hardarson SH, Stefansson E. Oxygen saturation in central retinal vein occlusion. Am J Ophthalmol. 2010;150(6):871–75. doi: 10.1016/j.ajo.2010.06.020. [DOI] [PubMed] [Google Scholar]
- 10.Geirsdottir A, Hardarson SH, Olafsdottir OB, Stefansson E. Retinal oxygen metabolism in exudative age-related macular degeneration. Acta Ophthalmol (Copenh) 2014;92(1):27–33. doi: 10.1111/aos.12294. [DOI] [PubMed] [Google Scholar]
- 11.Beach JM, Schwenzer KJ, Srinivas S, Kim D, Tiedeman JS. Oximetry of retinal vessels by dual-wavelength imaging: calibration and influence of pigmentation. J Appl Physiol (1985) 1999;86(2):748–58. doi: 10.1152/jappl.1999.86.2.748. [DOI] [PubMed] [Google Scholar]
- 12.Felder AE, Wanek J, Blair NP, Shahidi M. Inner retinal oxygen extraction fraction in response to light flicker stimulation in humans. Invest Ophthalmol Vis Sci. 2015;56(11):6633–37. doi: 10.1167/iovs.15-17321. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Hammer M, Vilser W, Riemer T, Schweitzer D. Retinal vessel oximetry-calibration, compensation for vessel diameter and fundus pigmentation, and reproducibility. J Biomed Opt. 2008;13(5):054015. doi: 10.1117/1.2976032. [DOI] [PubMed] [Google Scholar]
- 14.Hardarson SH, Harris A, Karlsson RA, Halldorsson GH, Kagemann L, Rechtman E, Zoega GM, Eysteinsson T, Benediktsson JA, Thorsteinsson A, et al. Automatic retinal oximetry. Invest Opthalmol Vis Sci. 2006;47(11):5011–16. doi: 10.1167/iovs.06-0039. [DOI] [PubMed] [Google Scholar]
- 15.Shahidi M, Shakoor A, Blair NP, Mori M, Shonat RD. A method for chorioretinal oxygen tension measurement. Curr Eye Res. 2006;31(4):357–66. doi: 10.1080/02713680600599446. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Shonat RD, Kight AC. Oxygen tension imaging in the mouse retina. Ann Biomed Eng. 2003;31(9):1084–96. doi: 10.1114/1.1603256. [DOI] [PubMed] [Google Scholar]
- 17.Song W, Wei Q, Liu W, Liu T, Yi J, Sheibani N, Fawzi AA, Linsenmeier RA, Jiao S, Zhang HF. A combined method to quantify the retinal metabolic rate of oxygen using photoacoustic ophthalmoscopy and optical coherence tomography. Sci Rep. 2014;4:6525. doi: 10.1038/srep06525. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Yi J, Wei Q, Liu W, Backman V, Zhang HF. Visible-light optical coherence tomography for retinal oximetry. Opt Lett. 2013;38(11):1796–98. doi: 10.1364/OL.38.001796. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Lau JC, Linsenmeier RA. Oxygen consumption and distribution in the Long-Evans rat retina. Exp Eye Res. 2012;102:50–58. doi: 10.1016/j.exer.2012.07.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Pournaras CJ, Riva CE, Tsacopoulos M, Strommer K. Diffusion of O2 in the retina of anesthetized miniature pigs in normoxia and hyperoxia. Exp Eye Res. 1989;49(3):347–60. doi: 10.1016/0014-4835(89)90045-6. [DOI] [PubMed] [Google Scholar]
- 21.Braun RD, Linsenmeier RA, Goldstick TK. Oxygen consumption in the inner and outer retina of the cat. Invest Ophthalmol Vis Sci. 1995;36(3):542–54. [PubMed] [Google Scholar]
- 22.Shahidi M, Wanek J, Blair NP, Little DM, Wu T. Retinal tissue oxygen tension imaging in the rat. Invest Ophthalmol Vis Sci. 2010;51:4766–70. doi: 10.1167/iovs.09-4710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Shahidi M, Wanek J, Blair NP, Mori M. Three-dimensional mapping of chorioretinal vascular oxygen tension in the rat. Invest Ophthalmol Vis Sci. 2009;50(2):820–25. doi: 10.1167/iovs.08-2343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Wanek J, Teng PY, Blair NP, Shahidi M. Inner retinal oxygen delivery and metabolism under normoxia and hypoxia in rat. Invest Ophthalmol Vis Sci. 2013;54(7):5012–19. doi: 10.1167/iovs.13-11887. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Teng PY, Wanek J, Blair NP, Shahidi M. Response of inner retinal oxygen extraction fraction to light flicker under normoxia and hypoxia in rat. Invest Ophthalmol Vis Sci. 2014;55(9):6055–58. doi: 10.1167/iovs.13-13811. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Wanek J, Blair NP, Shahidi M. Outer retinal oxygen consumption of rat by phosphorescence lifetime imaging. Curr Eye Res. 2012;37(2):132–37. doi: 10.3109/02713683.2011.629071. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Delaey C, Van De Voorde J. Regulatory mechanisms in the retinal and choroidal circulation. Ophthalmic Res. 2000;32(6):249–56. doi: 10.1159/000055622. [DOI] [PubMed] [Google Scholar]
- 28.Linsenmeier RA, Braun RD, McRipley MA, Padnick LB, Ahmed J, Hatchell DL, McLeod DS, Lutty GA. Retinal hypoxia in long-term diabetic cats. Invest Ophthalmol Vis Sci. 1998;39(9):1647–57. [PubMed] [Google Scholar]
- 29.Yu DY, Cringle SJ, Alder VA, Su EN. Intraretinal oxygen distribution in rats as a function of systemic blood pressure. Am J Physiol. 1994;267(6 Pt 2):H2498–507. doi: 10.1152/ajpheart.1994.267.6.H2498. [DOI] [PubMed] [Google Scholar]
- 30.Petropoulos IK, Pournaras JA, Stangos AN, Pournaras CJ. Preretinal partial pressure of oxygen gradients before and after experimental pars plana vitrectomy. Retina. 2013;33(1):170–78. doi: 10.1097/IAE.0b013e318261a6b5. [DOI] [PubMed] [Google Scholar]
- 31.Yu DY, Cringle SJ, Alder VA. The response of rat vitreal oxygen tension to stepwise increases in inspired percentage oxygen. Invest Ophthalmol Vis Sci. 1990;31(12):2493–99. [PubMed] [Google Scholar]
- 32.Alder VA, Yu DY, Cringle SJ, Su EN. Changes in vitreal oxygen tension distribution in the streptozotocin diabetic rat. Diabetologia. 1991;34(7):469–76. doi: 10.1007/BF00403282. [DOI] [PubMed] [Google Scholar]
- 33.Teng PY, Blair NP, Wanek J, Shahidi M. Oxygen tension and gradient measurements in the retinal microvasculature of rats. Graefes Arch Clin Exp Ophthalmol. 2012;250(3):361–67. doi: 10.1007/s00417-011-1859-6. [DOI] [PMC free article] [PubMed] [Google Scholar]